Jenna Philpott - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jenna Philpott's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jenna Philpott
Verified
Reporter, Medical Device Network
Beats
Breaking News , Health , Retail , Hawaii Business
Russian espionage, Middle Eastern politics, Climate Change
Content
By Jenna Philpott Verified| Pharmaceutical-Technology.com Verified The agreement adds to Eli Lilly’s growing portfolio of AI-enabled drug discovery partnerships. Eli Lilly will use BigHat’s AI-driven Milliner platform. Credit: Just_Super via Getty Images. Eli Lilly has signed a new research deal with BigHat Biosciences to co-develop next-generation antibody therapeutics, as the pharma company continues to expand its capabilities in artificial intelligence (AI)-driven drug development
By Jenna Philpott Verified| Pharmaceutical-Technology.com Verified Bluebird bio (bluebird) has reaffirmed its support for a proposed acquisition by Carlyle and SK Capital after rival bidder Ayrmid failed to deliver a binding offer or secure financing by the extended deadline. The announcement marks the second time Ayrmid has initiated discussions with bluebird without producing a fully financed proposal
Company Info
Medical Device Network
Medical Device Network is an industry information platform focused on the medical device sector. It provides news, analysis, and directories related to medical device supply chains, regulatory issues, and market trends. The platform serves as a resource for professionals in the industry, offering insights and listings of medical device manufacturers and service providers. Its revenue model likely includes advertising and lead generation through company profiles and sector reports.
'+1 646-625-7388